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Crop
bioengineering:
enormous
potential for
catalyzing
international
development
Introduction
Bioengineering provides unique and dramatic
opportunities for crop improvement. It can
be used to develop crop varieties that would
otherwise be unavailable and can facilitate
much faster and more precise ways of
developing improved varieties. It can help to
increase yields and reliability and thus reduce
food costs for the consumer while helping to
control input costs for farmers through
reduced applications of herbicides, pesticides,
and fertilizer.
The extent to which this will be achieved
depends on how effectively the global
scientific community – including both the
public and private sectors – can cooperate in
harnessing the power of crop bioengineering
and the allied scientific fields of genomics and
bioinformatics for the poor and hungry of the
world. This, in turn depends on the extent to

which projects are demand-driven and
holistic in approach, integrating all technical
and non-technical factors relevant to the
product development and commercialization/
delivery chain.

What are bioengineered
crops?
Crop bioengineering is the precise transfer of
desirable genes into a target crop plant
without the concomitant introduction of
non-desirable genes that conventional plant
breeding entails (often necessitating expensive and lengthy backcrossing schemes).
However, crop bioengineering is neither a
panacea nor a stand-alone, but rather a
biotechnological tool that complements
conventional, organic or other biotechnological approaches as part of an integrated
approach to crop improvement. The technology has already had considerable impact
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around the world – in industrialized and
developing countries. Most commercialization to date has focused on internationally
traded commodities such as maize, soybean,
cotton and canola. The major traits that have
been transferred into these crops include
herbicide tolerance (to facilitate improved
control of weeds and reduce tillage) and insect
resistance (to reduce the need for chemical
pesticide applications while improving pest
control) and, to a lesser extent, delayed
ripening, and virus resistance. Although the
global deployment of bioengineered crops has
dramatically expanded (from 10 million
hectares in 1997 to 125 million hectares in
2008) the dominant countries remain the
USA, Argentina, Brazil, India, Canada and
China (James, 2008).

Bioengineered crops are
needed for international
development
The range of bioengineered crop species
available to developing countries must be
expanded significantly if agricultural production is to keep pace with growing
populations, diminishing arable land,
relentless urbanization and an ever expanding
global appetite for meat consumption.
Whereas multinational life sciences companies have led the research, development and
commercialization of bioengineered crops,
their primary focus has been, and will likely
continue to be, on crops with traits having
commercial value as global commodities.
Meanwhile, many crops of extreme importance to subsistence and resource-poor
farmers around the world have been neglected. Such crops – often referred to as ‘orphan’
crops because of the relative lack of research
and development applied to them – can be
vitally important for nutrition and income in
poor regions. These crops cover 240 million
hectares in developing countries alone and

include plantain and bananas; root and tuber
crops such as potato cassava, sweet potato
and yam; millets such as pearl millet, finger
millet and foxtail millet; legumes such as
cowpeas, groundnut and Bambara groundnut; and tree crops. Moreover, indigenous
crops such as tef, quinoa and many types of
vegetables are critical for food security and
nutrition on a regional or local basis. Whereas
some of the production constraints associated
with these crops are being overcome by
conventional breeding and agronomic
approaches, for some crop/constraint combinations bioengineering is the only answer.
The long-term technological possibilities for
bioengineered crops are vast due to breakthroughs in genomics and bioinformatics1.
Ultimately plant genes encoding all agriculturally important traits will be more easily
identified and isolated and, through
bioengineering, transferred to target varieties.
By facilitating access to, and use of, desirable
genes in plant germplasm collections and
naturally occurring genetic resources, the
combination of genomics, bioinformatics and
bioengineering will indirectly contribute to
the improved conservation of biodiversity.
Plant germplasm collections that are put to
better practical use are less likely to be
abandoned due to budgetary cuts, and
ecosystems whose resources can be valorized
are less likely to be destroyed or wasted.

How can the full potential
of crop bioengineering be
tapped for international
development?
Safe and effective adoption of bioengineered
crops (including orphan crops) for the
developing world necessitates new project
approaches involving partnerships among all
relevant stakeholders. Depending on project
specifics, partners might include universities,
national and regional research organizations,

1 Genomics is the study of the whole genomes of organisms. The field includes intensive efforts to determine the

entire DNA sequence of organisms and fine-scale genetic mapping efforts. Bioinformatics is the application of
information technology to the field of genomics and other areas of molecular biology.
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the private sector, non-governmental organizations, government agencies, international
agricultural research centres and other stakeholders from developing and industrialized
countries who are involved in the researchdevelopment-commercialization/delivery
continuum.
Projects must be demand-driven with a
holistic and integrated approach that
considers every technical and non-technical
issue from the outset (Gregory et al., 2008). It
is essential in the planning and implementation of the work not to underestimate the
resources needed to move a bioengineered
crop from the research phase into the hands
of the end-user – a point that is often overlooked by public sector organizations such as
universities and national research institutes
which, historically, have focused almost
exclusively on the research phase.
Figure 1 outlines the actual stages of product
research, development and delivery that
typically need to be addressed once market
assessment and feasibility studies on the
candidate bioengineered crop have been
conducted. Of the 14 stages in the research–
development–commercialization/delivery
continuum, only five relate to research. The
cost of the other nine, non-research stages
typically represents two-thirds of the total
Figure 1. Stages in the
research–development–
commercialization/
delivery continuum
(Gregory et al., 2008)
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project. Obtaining regulatory approval for
new bioengineered crops can be a particularly
costly, major bottleneck.
Even though there are no known substantiated harmful effects of bioengineered crops
on human health or the environment, there
are theoretical environmental and health risks
associated with bioengineered crop production and use. Accordingly, a regulatory
package needs to be compiled to enable the
commercialization of each bioengineered
product. Compiling such a package can cost
more than a million dollars and involve up to
a decade of work. Due to these high costs it is
advisable, to the extent possible, to utilize
information from existing regulatory dossiers
generated in other countries for the same or
similar products. Depending on the focus
country involved, this activity can be
governed by national biosafety legislation and
the authorities responsible for its implementation. Much of what is needed is
codified; however, some of the work can
involve negotiation and perceptions of risk.
New data for the regulatory packages should
be generated as much as possible within the
focus country or region. An interactive
relationship with regulatory authorities needs
to be established – even at the outset of product development – and dialogue should be
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maintained throughout the time leading up
to the formal submission of the regulatory
package. Furthermore, regardless of any
demonstrable risk associated with bioengineered crops, the mere presence of
perceived risk raises the potential for liability
claims associated with the migration of
transgenes in local cropping systems.
Uncertainty about how this will be resolved
has resulted in reluctance from some
technology owners to donate appropriate
technology for developing country farmers.

Bioengineered crops,
germplasm, biodiversity
and property rights
The growing importance of property rights to
the development and use of bioengineered
crops relates to ongoing globalization and
harmonization of intellectual property rights
(IPR) regimes pursuant to the World Trade
Organization’s Trade-Related Aspects of
Intellectual Property agreement (TRIPS), the
Convention of the International Union for the
Protection of New Plant Varieties (UPOV) and
the Patent Cooperation Treaty (PCT), and also
the implementation of two international
accords which affect the accessibility of crop
germplasm and genetic resources, i.e., the
Convention on Biological Diversity (CBD) and
the International Treaty on Plant Genetic
Resources for Food And Agriculture
(ITPGRFA) (Kowalski, 2007).
This rather complex international web of
property rights has raised concerns in both
the private and public sectors. As mentioned
above, most of the advances in technology
development associated with bioengineered
crops have been made in the private sector,
which protects its inventions via IPR, that is,
patent portfolios and plant variety protection
(PVP) certificates. If, as we anticipate, crop
technology expands to encompass a much
broader range of traits and crops and new
markets emerge, such IPR protection will
likely increase, as is already evident when
considering the trend towards overlapping

IPR protection of commodity crops, i.e.,
layered patent, PVP, trade secret and
trademark protection in maize.
Regarding germplasm, if plant resources
become valuable reservoirs of genes for new
bioengineered crops, it will be essential to
address issues related to ownership of plant
genetic resources accessed from international, regional and national germplasm
collections and also from wild ecosystems.
Until the establishment of the CBD, free
exchange of genetic resources was the norm
under the common heritage principle.
However, the CBD now recognizes that
countries have sovereign rights to control and
use their genetic resources, and further
encourages these signatory governments to
formally regulate access to biodiversity. This
has thus led to a decrease in global
germplasm flow with regard to bioprospecting
involving wild crop relatives growing in their
natural habitats. The ITPGRFA, however,
seeks to facilitate access to existing crop
germplasm collections via its open-source
type IP provisions, i.e., agreement not to seek
IPR on any of the germplasm resources in the
form received, thus facilitating open and
continued access.
Weak IPR regimes in many developing
countries, an inadequate understanding of
the requirements and implications of IPR on
bioengineering technology and concerns
about the cost and potential liability
associated with IPR, can impede the roll-out
of bioengineered crops for developing
countries; however, this can be ameliorated if
national systems are augmented via
international collaborations and partnerships
coupled with concerted efforts towards
capacity building in both the technological
and legal frameworks requisite for advancing
crop biotechnology. Indeed, depending on
how it is managed, IPR can either delay or
accelerate access to biotechnological innovations. IPR management capability is therefore an integral component of the holistic
approach to delivering bioengineered crops to
developing countries.
29
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Conclusions
Bioengineered crops have already had
substantial impact in developing, as well as
industrialized, countries and they have
enormous potential for providing solutions to
important and previously intractable
problems facing subsistence and resourcepoor farmers in the developing world.
However, for this to become a reality it is
essential to address, from project inception to
termination, the complex technical and nontechnical issues associated with the
research–development–delivery continuum
for bioengineered crops. This requires a wide
range and depth of expertise and facilities that
extend far beyond the present or projected
capacities of most individual institutions or
even nations. Therefore, the full potential of
bioengineered crops as tools for international
development can be realized only if strong
emphasis is placed on inter-institutional
collaboration – including public and private
sector organizations – at the national,
regional and global levels, coupled with
focused and sustained capacity building at
both the human and institutional levels.

Perhaps most importantly, successful distribution of bioengineered crops requires a
communication strategy that provides regular, accurate information on the bioengineered product(s), not only to farmers
but also to local scientists, regulators,
journalists, extension workers, retailers, religious groups, consumers, non-governmental
organizations and others. This will facilitate
product acceptance, address concerns as they
arise and increase the likelihood of product
acceptance and continued development of
new bioengineered crops for the world’s poor
and hungry.
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Upcoming Events
2009
17 September

Marrying productivity and sustainability to achieve food security. Scottish Crops Research Institute,
Invergowrie, Dundee (TAA Scotland & North of England and SCRI)

20 October

Water - our most important resource. Royal Agricultural College, Cirencester (SouthWestRuralUpdate).
Details available from beverley.allen@rac.ac.uk

21 October

Ethiopia, with the theme of conservation which will include tree planting. Royal Agricultural College,
Cirencester (TAA South-West)

9 December

TAA AGM and 27th Annual Ralph memorial Lecture given by Chris Garforth. Royal Over-Seas League,
Park Place, St James’s Street, London

2010
8 January

30

Cambridge Conservation Forum Annual Symposium. Murray Edwards College (New Hall), Cambridge.
Amir Kassam and Francis Shaxson will give a presentation on TAA's work in Conservation Agriculture.
CCF website http://www.cambridgeconservationforum.org.uk/

